Comparison · NCT03070600-689938d0
Universal PrEP Counselling vs Targeted PrEP Clinics: PrEP Use
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Universal PrEP Counselling vs Targeted PrEP Clinics: PrEP Use. Trial comparisons, record NCT03070600-689938d0. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03070600-689938d0
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.176 | 0.161 | 0.193 | wilson | |
| Risk in group 2 | 0.147 | 0.133 | 0.162 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0294 | 0.00777 | 0.051 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.2 | 1.05 | 1.37 | log | |
| Odds ratio, group 1 over group 2 | 1.24 | 1.06 | 1.46 | log | |
| Number needed to treat, for one more participant with the outcome on Universal PrEP Counselling than on Targeted PrEP Clinics | 34 | 19.6 | 129 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Universal PrEP Counselling | All enrolled women receiving antenatal care at facilities assigned to Universal PrEP arm will receive standardized HIV risk counseling and then self-select whether they want to use PrEP.~Universal PrEP Counseling: Counseling at universal sites, will use a standardized counseling script to state that PrEP is available for women at risk for HIV, explain that HIV prevalence in the region is high, and will note that women with HIV positive partners or who don't know their partner's status may be at risk. Counseling will specify that women may have their own reasons to feel at risk or to want PrEP. Following standardized counseling, women will select PrEP at the same visit or will be allowed to deliberate on the decision and come back at the next visit with a decision. Women will be informed that it is advisable to use PrEP if they know their partner is HIV positive or if they do not know their partner's status and will be encouraged to bring untested partners to clinic if status is unknown. | 397 | 2,250 | OG000 |
| Group 2 | Targeted PrEP Clinics | All enrolled women receiving antenatal care at facilities assigned to the Targeted PrEP arm will be assessed for HIV-risk prior to receiving targeted PrEP counseling.~Targeted PrEP Counseling: Following enrollment, the targeted PrEP clinics will provide two inter-related innovations over two ANC visits. In the targeted PrEP clinics, any of the following three criteria can trigger enhanced PrEP counseling. A participant that meets any one of these criteria will receive PrEP counseling during the study visit where the criteria is met:~1. Risk Score \>6 (Risk score includes male partner status known/unknown, syphilis infection, and lifetime number of male partners) or any National AIDS and STI Control Programme (NASCOP) risk factors~2. participant declines partner self-tests regardless of partner HIV status, and/or~3. their partner declines self-testing or tests positive. | 323 | 2,197 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- PrEP Use
- Description
- PrEP Utilization by participants
- Time frame
- Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30).
- Population
Source ClinicalTrials.gov
Trial
- Title
- PrEP Implementation for Mothers in Antenatal Care
- NCT number
- NCT03070600
- Phases
- PHASE4
- Conditions
- HIV Infections, Pregnancy Related
- Interventions
- Universal PrEP Counseling, Targeted PrEP Counseling
- Lead sponsor
- University of Washington
- Results first posted
- 2022-05-10
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03070600?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03070600-689938d0